Association of Genetic Polymorphisms in TNF and MIF Gene with the Risk of Primary Dysmenorrhea

[1]  J. Grutters,et al.  Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome. , 2014, Cytokine.

[2]  T. Harada.  Dysmenorrhea and Endometriosis in Young Women , 2013, Yonago acta medica.

[3]  Shun-le Chen,et al.  A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease , 2013, Arthritis Research & Therapy.

[4]  J. Duan,et al.  Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study , 2013, PloS one.

[5]  R. Hui,et al.  Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke , 2012, Journal of Neuroinflammation.

[6]  Z. Fedorowicz,et al.  Beta2-adrenoceptor agonists for dysmenorrhoea. , 2012, The Cochrane database of systematic reviews.

[7]  S. Mastana,et al.  Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. , 2009, Biochimica et biophysica acta.

[8]  C. Cerquaglia,et al.  Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF‐173G/C polymorphism , 2007, Scandinavian journal of rheumatology.

[9]  T. Calandra,et al.  Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  F. Bolgert,et al.  Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain–Barré syndrome and experimental allergic neuritis , 2005, Journal of Neuroimmunology.

[11]  T. Calandra,et al.  Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.

[12]  W. Thomson,et al.  A novel 5′‐flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic‐onset juvenile idiopathic arthritis , 2001 .

[13]  W. Stolz,et al.  Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. , 2000, Molecular human reproduction.

[14]  J. Konje,et al.  Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. , 2000, Human reproduction update.

[15]  L. Abraham,et al.  Impact of the ‐308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease , 1999, Journal of leukocyte biology.

[16]  N. Martin,et al.  Longitudinal Genetic Analysis of Menstrual Flow, Pain, and Limitation in a Sample of Australian Twins , 1998, Behavior genetics.

[17]  Yuji Sato,et al.  Macrophage Migration Inhibitory Factor (MIF) , 1996 .

[18]  J. Bernhagen,et al.  An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction , 1996, The Journal of experimental medicine.

[19]  F. Pociot,et al.  No independent association between a tumor necrosis factor‐α promotor region polymorphism and insulin‐dependent diabetes mellitus , 1993, European journal of immunology.

[20]  R. Fields,et al.  Spatial summation of pre-pain and pain in human teeth , 1985, Pain.

[21]  J. Ballantyne,et al.  Psychosocial Aspects of Chronic Pelvic Pain , 2013 .

[22]  R. Bucala.  MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity , 2012, Journal of Clinical Immunology.

[23]  Z. Ye,et al.  Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. , 2008, Cytokine.

[24]  Yuji Sato,et al.  Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. , 2003, Annals of the New York Academy of Sciences.